November 15, 2022: Yuan Rijin, Chief Veterinary Physician of the Provincial Department of Agriculture and Rural Affairs, Conducts a Research Visit

Image Name

2022.11.15

Yuan Rijin, Chief Veterinary Officer of the Provincial Department of Agriculture and Rural Affairs, Conducts Research and Survey

 

West Mountain

Previous article

On August 14, 2023, our company successfully passed the CNAS re-evaluation and on-site assessment for scope expansion.

On June 20, 2023, the Suzhou Municipal Bureau of Agriculture and Rural Affairs and the Municipal Animal Disease Prevention and Control Center conducted a "Biosafety Supervision Review" at our company.

Next article

Previous article

On June 20, 2023, the Suzhou Municipal Bureau of Agriculture and Rural Affairs and the Municipal Animal Disease Prevention and Control Center conducted a "Biosafety Supervision Review" at our company.

Next article

On June 20, 2023, the Suzhou Municipal Bureau of Agriculture and Rural Affairs and the Municipal Animal Disease Prevention and Control Center conducted a "Biosafety Supervision Review" at our company.

More information

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

[Suzhou, May 10, 2025] Recently, our company’s Nano Park facility successfully completed the filing process for its P2 laboratory with the Suzhou Municipal Bureau of Agriculture and Rural Affairs, officially becoming one of the first animal pathogen microbiology laboratories in the entire Suzhou metropolitan area to receive approval under the newly implemented "Jiangsu Province Animal Pathogen Microbiology Laboratory Filing Management Measures" (effective February 1, 2025).

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

Recently, our company successfully passed the on-site expansion review for CMA accreditation, marking official recognition from a national authority of our professional expertise and robust quality management system in the field of laboratory animal testing. The review took place from September 1 to September 2, 2024, during which the expert panel conducted a comprehensive and rigorous assessment of our laboratory animal testing technologies, equipment, personnel, and management systems—ultimately confirming that we meet the relevant CMA standards.

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024 – Our company has officially obtained the Veterinary Drug Production License and the Veterinary Drug GMP Certificate issued by the Ministry of Agriculture and Rural Affairs, marking that our company’s quality management system and technical capabilities in the veterinary drug manufacturing sector have met the nation’s stringent high-standard requirements. During this certification process, our immunology-based diagnostic product (Class B) production line successfully passed the on-site GMP inspection for veterinary drugs and was recognized as a qualified production line, laying a solid foundation for the company to further expand into the veterinary diagnostic reagent market.